Award
NIH Reporter #5R01CA289500-03
Overcoming Therapy Resistance in SCLC
Recipient
UT Southwestern Medical Center
Award Amount
$498,927.00
Ceiling
$498,927.00
Awarded
February 06, 2026
Identifier
5R01CA289500-03
The project studies a telomerase-targeting molecule as a potential way to improve treatment of small cell lung cancer, including in combination with radiation or chemotherapy. It aims to understand effects on tumor immunity and resistance to current treatments.
Description
NIH-funded project investigating how targeting telomerase can sensitize small cell lung cancer to radiation or chemotherapy, induce immune responses, and overcome resistance to existing treatments.